Filing Flows › Comparisons › ABEO vs CAPR
Abeona Therapeutics vs Capricor Therapeutics: ABEO and CAPR compared
Abeona Therapeutics is the larger company: $11.4M of revenue in its latest quarter (Q2 2026) against $11.1M for Capricor Therapeutics (Q4 2024). Abeona Therapeutics is growing faster (28× against -8% a year earlier). Capricor Therapeutics is more profitable, with an operating margin of -69.1% against -120.0%.
Where the money goes: ABEO and CAPR
Abeona Therapeutics (ABEO) · Q2 2026
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart follows the revenue to costs, profit and cash.
Capricor Therapeutics (CAPR) · Q4 2024
Capricor Therapeutics, Q4 2024: revenue $11.1M (-8% year over year), operating margin -69.1%, net loss $7.1M, operating cash flow −$14.8M. The chart follows the revenue to costs, profit and cash.
| Abeona Therapeutics (ABEO) | Capricor Therapeutics (CAPR) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 2024 |
| Revenue | $11.4M | $11.1M |
| Revenue growth, Y/Y | 28× | -8% |
| Operating margin | -120.0% | -69.1% |
| Net earnings | −$20.2M | −$7.1M |
| Net margin | -177.4% | -63.9% |
| Operating cash flow | −$17.5M | −$14.8M |
Questions
Which is bigger, Abeona Therapeutics or Capricor Therapeutics?
Abeona Therapeutics is the larger company: $11.4M of revenue in its latest quarter (Q2 2026) against $11.1M for Capricor Therapeutics (Q4 2024).
Is Abeona Therapeutics or Capricor Therapeutics growing faster?
Abeona Therapeutics is growing faster (28× against -8% a year earlier).
Which is more profitable, Abeona Therapeutics or Capricor Therapeutics?
Capricor Therapeutics is more profitable, with an operating margin of -69.1% against -120.0%.
More: Abeona Therapeutics earnings · how Abeona Therapeutics makes money · Capricor Therapeutics earnings · how Capricor Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-K filed Mar 26, 2025). Fiscal quarters can end on different dates. Not investment advice.